obesity drug news today october 21 2025 glp-1 Drugs Market Size to Hit USD 132.79 Bn by 2035 Study finds 40% of GLP-1

It can also be used for weight loss in combination with other drugs

PL detail-document

FUNDING This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), South Korea, funded by the Ministry of Education (NRF-2021R1A2C2008792)

This launch comes in response to the growing conversation around GLP-1 medications, which have gained popularity for their role in weight management and diabetes treatment

We have lab, animal, clinical, and cohort data testifying to their broad effects

Consistent with this, GLP-1, exendin-4, and the DPP-4 inhibitor sitagliptin reduced proximal tubular sodium reabsorption in rats [660,761,769,770] and humans [663]